Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi
Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace
Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace
Fitzgerald resigns four months after ex-HHS Secretary Price. Source: BioSpace
Celltrion are down more than 5 percent after the company announced it received a warning letter from the FDA after the regulatory agency inspected a company drug manufacturing facility. Source:…
Sluggish growth is the main driver for the decision.. Source: BioSpace
Vertex is keeping its promise of advancing triple combination treatments for patients with cystic fibrosis and investors are happy. Source: BioSpace
The company plans to initiate a Phase 2 clinical trial this year with AVR-RD-01 in Fabry disease. Source: BioSpace
The company is now waiting for the FDA to determine a path forward in resuming clinical studies. Source: BioSpace
The bill would allow access to experimental treatments for patients with terminal conditions. Source: BioSpace
The companies were evaluated extensively on Career Pages, Job Boards, Employee Reviews & Candidate Engagement, Accolades, Recruitment Marketing, and Social Responsibility. Source: BioSpace
The company expects to only pay a tax rate of 9 percent this year, which will free up a lot of cash. Source: BioSpace